Vitura Health Ltd

AU:VIT Australia Drug Manufacturers - Specialty & Generic
Market Cap
$16.82 Million
AU$27.17 Million AUD
Market Cap Rank
#30723 Global
#905 in Australia
Share Price
AU$0.04
Change (1 day)
+5.13%
52-Week Range
AU$0.04 - AU$0.08
All Time High
AU$0.96
About

Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for alternative therapies; Doctors on Demand, a premier provider of on-demand virtual h… Read more

Vitura Health Ltd - Asset Resilience Ratio

Latest as of June 2024: 16.76%

Vitura Health Ltd (VIT) has an Asset Resilience Ratio of 16.76% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
AU$11.94 Million
Cash + Short-term Investments
Total Assets
AU$71.28 Million
All company assets
Resilience Assessment
Good
Financial Resilience Level

Asset Resilience Ratio Trend (2024–2024)

This chart shows how Vitura Health Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Vitura Health Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$0.00 0%
Short-term Investments AU$11.94 Million 16.76%
Total Liquid Assets AU$11.94 Million 16.76%

Asset Resilience Insights

  • Good Liquidity Position: Vitura Health Ltd maintains a healthy 16.76% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Vitura Health Ltd Industry Peers by Asset Resilience Ratio

Compare Vitura Health Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
Drug Manufacturers - Specialty & Generic -0.02%
Kamada
NASDAQ:KMDA
Drug Manufacturers - Specialty & Generic 21.63%
Dongwha Pharm.Co.Ltd
KO:000020
Drug Manufacturers - Specialty & Generic 1.92%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.46%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%
Kotra Industries Bhd
KLSE:0002
Drug Manufacturers - Specialty & Generic 9.82%
Yuyu Pharma Inc
KO:000227
Drug Manufacturers - Specialty & Generic 1.74%

Annual Asset Resilience Ratio for Vitura Health Ltd (2024–2024)

The table below shows the annual Asset Resilience Ratio data for Vitura Health Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-06-30 16.76% AU$11.94 Million AU$71.28 Million --
pp = percentage points